单域抗体-研究和治疗过敏的新工具
Ines Zettl1, Clarissa Bauernfeind1,2, Jessica Kollárová1
1Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
International journal of molecular sciences
|July 27, 2024
概括
纳米体通过准关键分子显示出对治疗过敏的希望. 本综述探讨了它们在诊断和治疗方面的潜力,并解决了未来过敏治疗的发展挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 通过IgE介导的过敏是全球重要的健康问题.
- 目前的治疗包括过敏原特异性免疫疗法 (AIT) 和针对过敏路径分子的生物药物.
- 纳米体是一种新的生物治疗药物,正在成为过敏学中宝贵的工具.
研究的目的:
- 审查开发基于纳米体的过敏药物候选药物的先决条件.
- 总结目前对纳米体进行过敏监测,检测和治疗的研究.
- 讨论纳米体在过敏治疗中的局限性和未来应用.
主要方法:
- 在过敏学中纳米体应用的文献综述.
- 对纳米体开发需求和挑战的分析.
- 探索基于纳米体的新型过敏治疗策略.
主要成果:
- 纳米体为过敏的过敏原检测和治疗干预提供了潜力.
- 纳米体药物开发的关键考虑因素包括体内半衰期和免疫性.
- 研究强调了纳米体在过敏学中的日益重要.
结论:
- 纳米体在过敏诊断和治疗方面是一个有前途的前沿.
- 解决发展障碍对于实现其全部临床潜力至关重要.
- 未来的应用可能包括创新的基于纳米体的过敏治疗格式.
相关概念视频
Antibody Structure
59.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.8K
Cross-reactivity
31.0K
Overview
31.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264
Allergic Drug Reactions
827
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
827
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Antibody Structure and Classes
861
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
861


